Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Kynurenic Acid | 1 | 2021 | 26 | 0.23 | Why? |
| Mycoplasma | 1 | 2018 | 36 | 0.19 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2018 | 143 | 0.17 | Why? |
| Genetic Engineering | 1 | 2018 | 325 | 0.15 | Why? |
| Saliva | 2 | 2021 | 4679 | 0.13 | Why? |
| Sex Characteristics | 1 | 2020 | 1120 | 0.12 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 1439 | 0.12 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.10 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.10 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.10 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.10 | Why? |
| T-Lymphocytes | 2 | 2020 | 6670 | 0.08 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.07 | Why? |
| Nasopharynx | 2 | 2020 | 10224 | 0.07 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.06 | Why? |
| Molecular Probe Techniques | 1 | 2020 | 65 | 0.05 | Why? |
| RNA Probes | 1 | 2020 | 106 | 0.05 | Why? |
| Interleukin-5 | 1 | 2020 | 138 | 0.05 | Why? |
| Tryptophan | 1 | 2021 | 218 | 0.05 | Why? |
| RNA Stability | 1 | 2021 | 285 | 0.05 | Why? |
| Metabolic Networks and Pathways | 1 | 2021 | 285 | 0.05 | Why? |
| Microorganisms, Genetically-Modified | 1 | 2018 | 19 | 0.05 | Why? |
| Interleukin-13 | 1 | 2020 | 204 | 0.05 | Why? |
| Riboswitch | 1 | 2018 | 34 | 0.05 | Why? |
| Tetracycline | 1 | 2018 | 33 | 0.05 | Why? |
| Luminescent Proteins | 1 | 2018 | 142 | 0.04 | Why? |
| Aminoglycosides | 1 | 2018 | 94 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2020 | 557 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| DNA Primers | 1 | 2020 | 1170 | 0.04 | Why? |
| Metabolomics | 1 | 2021 | 921 | 0.04 | Why? |
| Capacity Building | 1 | 2021 | 683 | 0.04 | Why? |
| Chemokines | 1 | 2020 | 1095 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Eosinophils | 1 | 2020 | 848 | 0.03 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 624 | 0.03 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.03 | Why? |
| Gene Regulatory Networks | 1 | 2018 | 820 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| RNA | 1 | 2020 | 1278 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Methyltransferases | 1 | 2018 | 720 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Smell | 1 | 2021 | 1851 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.03 | Why? |
| Multivariate Analysis | 1 | 2021 | 5440 | 0.03 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Resource Allocation | 1 | 2021 | 1771 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.02 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.02 | Why? |
| CRISPR-Cas Systems | 1 | 2018 | 1397 | 0.02 | Why? |
| Self Report | 1 | 2021 | 3802 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Monocytes | 1 | 2020 | 2978 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| HEK293 Cells | 1 | 2020 | 8394 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Genetic Variation | 1 | 2020 | 3919 | 0.02 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Humans | 9 | 2021 | 930598 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| United States | 2 | 2021 | 46150 | 0.02 | Why? |
| Male | 5 | 2021 | 367725 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Female | 5 | 2021 | 380317 | 0.02 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Adult | 3 | 2021 | 244371 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
Moore's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(134)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_